Forget keto — Ozempic might finally kill the low-carb diet trend
The popularity of weight loss drugs like semaglutide may burst the low-carb diet bubble.
Anna Fedorova/Getty Images
- Weight loss drugs like Ozempic are overtaking keto in popularity, a new report shows.
- GLP-1 drugs lead to significant weight loss and are changing consumer habits.
- But high costs and limited access to GLP-1s keep low-carb diets relevant to an extent.
Hold the butter — the rise of weight loss medications may be signaling an end to popular high-fat, low-carb diet trends.
Заголовки